Related Experiment Video

Updated: Aug 5, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

The Cooper Clinic Mortality Risk Index: clinical score sheet for men

Ian Janssen1, Peter T Katzmarzyk, Timothy S Church

  • 1School of Physical and Health Education, Queen's University, Kingston, Ontario, Canada.

American Journal of Preventive Medicine
|September 20, 2005
PubMed

Insights

A new scoring system, the Cooper Clinic Mortality Risk Index, accurately predicts all-cause mortality in men using clinical factors like age and fitness. This tool helps identify individuals who may need interventions to reduce mortality risk.

Area of Science:

  • Cardiovascular Health
  • Preventive Medicine
  • Biostatistics

Background:

  • Clinical measures for disease risk can also predict overall mortality.
  • A validated scoring system for all-cause mortality in men is needed.

Purpose of the Study:

  • To derive and validate a clinical scoring system for predicting all-cause mortality risk in men.
  • To utilize readily available clinical data for risk assessment.

Main Methods:

  • A prospective cohort study of 21,766 men (aged 20-69) without prior cardiovascular disease or cancer.
  • Development of a point scoring system using proportional hazards regression in a derivation group.
  • Validation of the scoring system in a separate validation group.

Main Results:

  • The Cooper Clinic Mortality Risk Index assigns points for age, diabetes, smoking, obesity, fitness, heart rate, and hypertension.
  • A graded relationship between risk points and mortality was observed.
  • The scoring system accurately predicted mortality risk in the validation group.

Conclusions:

  • The Cooper Clinic Mortality Risk Index is a validated tool for predicting all-cause mortality in men.
  • This score sheet can aid healthcare practitioners in identifying high-risk patients.
  • Identified high-risk patients may benefit from lifestyle changes or medical interventions.
Abstract

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of interest.
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...